Intersect ENT: 2Q Earnings Snapshot
MENLO PARK, Calif. (AP) _ Intersect ENT Inc. (XENT) on Wednesday reported a loss of $4.2 million in its second quarter.
The Menlo Park, California-based company said it had a loss of 14 cents per share.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The maker of absorbable nasal implants posted revenue of $26.3 million in the period, which missed Street forecasts. Six analysts surveyed by Zacks expected $28.1 million.
For the current quarter ending in October, Intersect ENT said it expects revenue in the range of $23.8 million to $24.3 million.
The company expects full-year revenue in the range of $106 million to $109 million.
Intersect ENT shares have dropped slightly since the beginning of the year. The stock has risen 18 percent in the last 12 months.